The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial

on behalf of the PAADRN Investigators

Research output: Contribution to journalArticlepeer-review

Abstract

Summary: In a large, pragmatic clinical trial, we calculated the costs of achieving four successful patient-centered outcomes using a tailored patient activation DXA result letter accompanied by a bone health brochure. The cost to achieve one successful outcome (e.g., a 0.5 standard deviation improvement in care satisfaction) ranged from $127.41 to $222.75. Introduction: Pragmatic randomized controlled trials (RCTs) should focus on patient-centered outcomes and report the costs for achieving those outcomes. We calculated per person incremental intervention costs, the number-needed-to-treat (NNT), and incremental per patient costs (cost per NNT) for four patient-centered outcomes in a direct-to-patient bone healthcare intervention. Methods: The Patient Activation after DXA Result Notification (PAADRN) pragmatic RCT enrolled 7749 patients presenting for DXA at three health centers between February 2012 and August 2014. Interviews occurred at baseline and 52 weeks post-DXA. Intervention subjects received an individually tailored DXA result letter accompanied by an educational bone health brochure 4 weeks post-DXA, while the usual care subjects did not. Outcomes focused on patients (a) correctly identifying their results, (b) contacting their providers, (c) discussing their results with their providers, and (d) satisfaction with their bone healthcare. NNTs were determined using intention-to-treat linear probability models, per person incremental intervention costs were calculated, and costs per NNT were computed. Results: Mean age was 66.6 years old, 83.8% were women, and 75.3% were non-Hispanic whites. The incremental per patient cost (costs per NNT) to increase the ability of a patient to (a) correctly identify their DXA result was $171.07; (b) contact their provider about their DXA result was $222.75; (c) discuss their DXA result with their provider was $193.55; and (d) achieve a 0.5 SD improvement in satisfaction with their bone healthcare was $127.41. Conclusion: An individually tailored DXA result letter accompanied by an educational brochure can improve four patient-centered outcomes at a modest cost. Trial registration: clinicaltrials.gov identifier NCT01507662.

Original languageEnglish (US)
Pages (from-to)3061-3066
Number of pages6
JournalOsteoporosis International
Volume28
Issue number10
DOIs
StatePublished - Oct 1 2017
Externally publishedYes

Keywords

  • Clinical trials
  • Costs
  • DXA
  • Osteoporosis
  • Patient activation

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial'. Together they form a unique fingerprint.

Cite this